Best Biopharma Outsourcing Companies in Pune, India
The 40 best Biopharma Outsourcing companies in Pune, India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Bilcare.
Our analysis of 50 Biopharma Outsourcing companies
$3.9b in tracked funding; 60% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2021.
Ranked: Best Biopharma Outsourcing companies in Pune
| # | Company | Disclosed funding | Revenue | Revenue YoY | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Bilcare Company offering innovative solutions for pharma packaging, clinical supplies and anti-counterfeiting 55Innovation top 19%Patents top 19%Moat top 25%Fin. health top 34% All 11 signals ▾Innovationtop 19% Patentstop 19% Moattop 25% Fin. healthtop 34% Fundingtop 38% Markettop 46% Globaltop 50% Talentbottom 49% Growthbottom 35% Techbottom 32% Newsbottom 21% Innovation: 108 patents (top 18% of patent-holders) · 7 filings since 2022 vs 4 in 2017-21 Patents: 108 patents matched (strict assignee match) · 7 filings since 2022 vs 4 in 2017-21 rank vs industry peers · Fliar Intelligence Index 55/100 | $149M | $91M FY2025 | +6% | 94 | 1993 | Mohan Bhandari Founder & CEO | 106 patents High‑barrier, PVC‑free cold‑formable multilayer blister packaging and product authentication | — |
| 2 | Enzene Company specializing in development of Biosimilars 72Growth top 32%Tech top 33%Funding top 35%Fin. health top 36% All 10 signals ▾Growthtop 32% Techtop 33% Fundingtop 35% Fin. healthtop 36% Moattop 37% Talenttop 38% Markettop 44% Producttop 45% Globalbottom 46% Newsbottom 21% Growth: Headcount 481 → 590 (+23%) across vintages · Revenue +35% YoY Tech: 46 technologies across 5/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 72/100 | $50M | $46M FY2025 | +35% | 590 590 → 1,019 (+73%) · sector median +75% | 2015 | Kannasandra Pushpalatha Co-Founder | — | — |
| 3 | SAVA group Pharma company with a portfolio of domestic and export products, also offering CRAMS services | — | $34M FY2025 | +14% | 368 | 2003 | Aniruddha Rajurkar CEO | — | — |
| 4 | Cilicant Manufacturer and supplier of drugs for biopharma sector | $2M | $20M FY2025 | +34% | 175 | 2011 | Rishika Manish Jain Co-Founder | — | — |
| 5 | Lavender Laboratries Pharmaceutical company offering contract research and analytical development services | — | $9M FY2025 | +29% | 103 | 2012 | — | — | — |
| 6 | Indus Biotech Specialty company developing products for autoimmune, CNS, Infectious and lifestyle diseases | $5M | $8M FY2025 | +2% | 121 121 → 164 (+36%) · sector median +75% | 1997 | Ranjeet Srinivasan Founder | 221 patents Phytochemical-based pharmaceutical compositions for autoimmune, respiratory, and neuro-inflammatory therapies | — |
| 7 | Ross Lifescience Provider of drug development, regulatory and analytical services | — | $7M FY2022 | — | 129 | 2008 | Kedar Deobhankar CEO | 4 patents Insect repellent chemical formulations and application methods for agricultural pest control | — |
| 8 | INTOX lab Provider of preclinical services | — | $5M FY2025 | -20% | 80 | 1995 | — | — | — |
| 9 | SKP India Provider of pharmaceutical product supply chain solutions | — | $5M FY2025 | +302% | — | 2016 | — | — | — |
| 10 | Synergen Bio Provider of consulting services to biopharma | — | $4M FY2025 | +2% | 77 77 → 189 (+145%) · sector median +75% | 2018 | Neel Lahoti Founder & CEO | — | 1 job opening |
| 11 | Maple Biotech Manufacturer of chemicals, and pharmaceutical food excipients | — | $3M FY2025 | +24% | — | 1982 | — | — | 6 launchs · 1 partnership |
| 12 | Quantime World Provider of packaging & labeling services for biopharma sector | — | $3M FY2022 | — | 23 23 → 36 (+57%) · sector median +75% | 2015 | Swapnil Deshmane Managing Director | — | 1 job opening |
| 13 | Aquigen Bio CDMO focused on manufacturing of APIs | — | $2M FY2025 | +6% | — | 2018 | Maruti Jagtap Founder & Managing Director | — | — |
| 14 | Shantani Proteome Analytics Drug discovery and development services using its chemical-proteomics technologies | $1M | $1M FY2025 | — | 10 | 2010 | Vikas Saxena Director | 17 patents Indazole-based small molecules for diabetes therapy and synthesis methods. | — |
| 15 | Callidus Research Laboratories Formulation development services for solid, semi-solid and liquid dosage forms | — | $1M FY2025 | +6% | 39 39 → 69 (+77%) · sector median +75% | 2015 | — | — | — |
| 16 | Ethosh Provider of digital experience and marketing services to health-tech and life-sciences organizations | $275K | $1M FY2025 | -34% | 37 37 → 88 (+138%) · sector median +75% | 2012 | — | — | — |
| 17 | Geneombio Technologies Provider of molecular diagnostic, contract research and animal genetic services | — | $749K FY2025 | +4% | 35 35 → 59 (+69%) · sector median +75% | 2005 | Anagha Purohit Co-Founder | — | — |
| 18 | BioRadius Contract research organization specializing in clinical trials, and bio-analytical services | — | $536K FY2025 | -26% | — | 2018 | — | — | — |
| 19 | Indo Bioactive Labs Company offering CDMO services for the development of heparin and peptide-based therapeutics | $115K | $467K FY2025 | -17% | — | 2001 | Dinesh Bothra Founder | — | — |
| 20 | Synapse Labs Contract research services for generic drugs development | — | $404K FY2025 | -83% | 104 | 2007 | Vishal Dhawan Founder & Director | — | — |
| 21 | Avieum Life Sciences Synthetic and medicinal chemistry, FBDD and process development services for drug development | — | $392K FY2019 | +545% | — | 2017 | — | — | — |
| 22 | MBWorld Exim Provider of formulation services to biopharma | — | $332K FY2025 | +16% | — | 2016 | — | — | — |
| 23 | Souvin Pharmaceuticals Developing and manufacturing services for APIs and intermediates | — | $274K FY2025 | -72% | — | 2010 | Rajeshwari Sidagouda Biradar Co-Founder & Director | — | — |
Top 8 Biopharma Outsourcing companies in Pune
#1
Series C · Pune, Maharashtra · founded 2015 · 590 employees$50Mraised▾
Enzene Biosciences Ltd., a subsidiary of Alkem Laboratories Limited, is uniquely poised to lead the new wave of global biosimilars development. Enzene has established several technology platforms in the areas of molecular biology, protein expression, fermentation technology (microbial, insect and mammalian cells), bio-analytics, immunology and peptide synthesis. The areas of expertise are: Proprietary expression vectors, Upstream Process Development for microbial, insect and mammalian cells, Downstream Process Development. Development of analytical tools to characterize peptides, proteins and mAbs, Cell Based Bioassay Development, Peptide Synthesis: Solution and Solid State
- Jan 2023Series C$50M
#2
Seed · Pune, Maharashtra · founded 2011 · 175 employees$2Mraised▾
Producer of packaging products for pharmaceutical and medical device manufacturers based in Pune, India. The company produces desiccants manufacturing and active pharmaceutical packaging products, offering some of the most superior quality desiccants to protect highly moisture and oxygen-sensitive products, enabling companies to maintain and sustain the potency.
- Feb 2021Seed$1.9M
- Feb 2019Seed$12.4K
- Nov 2016Angel$40.2K
- Mar 2015Angel$129.1K
#3
Acquired · Pune, Maharashtra · founded 1993 · 94 employees$149.4Mraised▾
Bilcare is a pharma packaging solutions provider. The company has 3 major divisions - Pharmaceutical Packaging International (PPI), Global Clinical Material Supplies (GCS) and non-clonable ID technologies. The PPI division offers packaging solutions mainly for solid dose packaging through specialty Polymer Films and Aluminum Foils. The GCS division offers clinical trial supply management services such as clinical supplies packaging and labelling, controlled-temperature (cold chain) CTM storage, worldwide distribution and returns and destructions accountability etc. The non-clonable ID technologies division offers track and trace, authentication and Anti-counterfeit (trademarked nCID technology - nonclonableID) solutions for product; people ID authentication and security. The company has 9 manufacturing facilities spread across Europe, US and Asia. Bilcare's clientele includes Bristol-Myers Squibb, Dr. Reddy’s, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Ranbaxy, Sanofi-Aventis, and Teva, among others.
- Aug 2014Conventional Debt$116.1M
- Feb 2010Post IPO$33.3M
#4
Seed · Pune, Maharashtra · founded 2010 · 10 employees$1Mraised▾
Drug discovery and development services using its chemical-proteomics technologies. The proprietary chemical proteomics technology platform provides two proprietary workflows (SCLS & UPT) which give information on the target and the action mechanism of bioactive molecules using the combination of chemical biology, biophysics, and cell molecular biology methods. I
- Jan 2015Seed$181.6K
- Jun 2013Seed$579.4K
- Jun 2012Seed$182.2K
- May 2011Seed$44.4K
#5
Series A · Pune, Maharashtra · founded 1997 · 121 employees$5.3Mraised▾
Indus Biotech is a drug discovery company focused on identifying and developing drugs for autoimmune, oncology, central nervous system (CNS), infectious, and lifestyle diseases. Current Products include torabolic for mass building, testosurge for increasing bio-availability of testosterone, biocreat for increasing bioavailability of creatine to muscle tissue, and testofen for increasing libido.
- 2007Series A$5.3M
#6
Seed · Pune, Maharashtra · founded 2012 · 37 employees$275.1Kraised▾
Provider of digital experience and marketing services to health-tech and life-sciences organizations. Its other services, include Virtual Product Demonstrations, Targeted Digital Marketing Campaigns, Interactive Experiences, Market Strategies, AR and VR, API development, Data Science, and AI/ML Integration.
- Dec 2016Angel$275.1K
#7
Seed · Pune, Maharashtra · founded 2001$115.1Kraised▾
Company offering CDMO services for the development of heparin and peptide-based therapeutics
- Mar 2007Seed$115.1K
#8
Seed · Pune, Maharashtra · founded 2005 · 35 employees$5.2Mraised▾
Genombio Technologies is a genomic services company primarily focussed on providing molecular diagnostic services, contract research services, and animal genetic services. It provides molecular diagnostic services such as bacterial pathogen PCR test, viral pathogen PCR test, Karyotyping test, Fluorescent In Situ Hybridization Test etc., As part of their contract research services they offer DNA Sequencing, DNA Cloning, Bacterial Identification, Fungal Identification and DNA Fingerprinting, Gene Expression Services, Pharmacogenomics Services, etc., As part of animal genetic services they offer genetic diseases, animal karyotyping test etc., They are NABL compliant and DSIR approved. The company claim to be the first to bring down the price of genotype based HIV-I Drug resistance test by developing a sophisticated test which has been validated by TreatAsia (Bangkok) and National Research Laboratories (Australia).
- Jul 2009Angel—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time falling
Funding & growth over time
funding flat · growth rising
What Pune researches in biotechnology
- Savitribai Phule Pune University11
- Symbiosis International University6
- Indian Institute of Science Education and Research Pune6
- Dr. D.Y. Patil Vidyapeeth, Pune3
- Institute of Cellular and Intracellular Symbiosis2
Who's building biotechnology IP in Pune
- Serum Institute of India224Pune
- National Centre for Cell Sciences17Pune
- Kirloskar Integrated Technologies5Pune
- Seagull BioSolutions5Pune
- Vision Next Foundation2Pune
- Dr Nilesh S. Patil-Rheumatologist1Pune
- Sentient Labs1Pune
- Cedar Healthcare & Life Science Private Limited1Pune
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.